{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:17:47Z","timestamp":1767050267821,"version":"3.48.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04005-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:52:57Z","timestamp":1764064377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LTBP2 promotes meningioma progression by enhancing glycolysis via the PI3K\/AKT\/mTOR\/c-Myc signaling pathway"],"prefix":"10.1007","volume":"16","author":[{"given":"Xuemin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonggong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"4005_CR1","doi-asserted-by":"crossref","unstructured":"Sahm F, Perry A, Meningiomas. Greenfield\u2019s Neuropathology 10e Set. CRC; 2021. pp. 1711\u201334.","DOI":"10.1201\/9781003389699-60"},{"issue":"2","key":"4005_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuchi.2020.10.005","volume":"67","author":"A Salami","year":"2021","unstructured":"Salami A, Okunlola A, Ajani M, Onakpoma F. WHO classification of meningiomas\u2013A single institutional experience. Neurochirurgie. 2021;67(2):119\u201324.","journal-title":"Neurochirurgie"},{"issue":"3","key":"4005_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biomedicines9030319","volume":"9","author":"C Ogasawara","year":"2021","unstructured":"Ogasawara C, Philbrick BD, Adamson DC. Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions. Biomedicines. 2021;9(3):319.","journal-title":"Biomedicines"},{"issue":"1","key":"4005_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5296\/jbls.v15i1.21286","volume":"15","author":"A Bharathiraja","year":"2024","unstructured":"Bharathiraja A. The role of sex hormones and race disparities in meningioma incidence: A comprehensive review. J Biology Life Sci. 2024;15(1):64\u201373.","journal-title":"J Biology Life Sci"},{"issue":"16","key":"4005_CR5","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.3390\/cancers14163995","volume":"14","author":"MV Corniola","year":"2022","unstructured":"Corniola MV, Meling TR. Management of recurrent meningiomas: state of the Art and perspectives. Cancers. 2022;14(16):3995.","journal-title":"Cancers"},{"issue":"4","key":"4005_CR6","doi-asserted-by":"publisher","first-page":"e8781","DOI":"10.1002\/ccr3.8781","volume":"12","author":"D Singh","year":"2024","unstructured":"Singh D, Scalia G, Mathand VU, Chaurasia B. Cystic meningiomas: A complex diagnostic challenge and clinicopathological insights from a unique case presentation. Clin Case Rep. 2024;12(4):e8781.","journal-title":"Clin Case Rep"},{"key":"4005_CR7","doi-asserted-by":"crossref","unstructured":"Sales AHA, Steiert C, Behringer SP, Bissolo M, Omer M, Loidl TB et al. Falcotentorial Meningiomas: Insights from Surgical Strategies and Clinical Outcomes. Journal of clinical medicine. 2024;13(7).","DOI":"10.3390\/jcm13071963"},{"issue":"1","key":"4005_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12262-021-03133-1","volume":"84","author":"T Kalayci","year":"2022","unstructured":"Kalayci T, Iliklerden UH. The role of latent transforming growth factor \u03b2 binding protein 2 (LTBP2) in the diagnosis and stage discrimination of gastric cancer. Indian J Surg. 2022;84(1):164\u20139.","journal-title":"Indian J Surg"},{"key":"4005_CR9","doi-asserted-by":"crossref","unstructured":"Zhang Y, Qin Y, Yu X. Decreased LTBP2 expression inhibits proliferation and migration of glioma. Mol Cell Toxicol. 2024:1\u20139.","DOI":"10.1007\/s13273-024-00447-5"},{"issue":"8","key":"4005_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41419-020-02851-w","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang C, Li N, Wang F, Xu Y, Shen Z, et al. The circEPSTI1\/mir-942-5p\/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K\/Akt\/mTOR pathway. Cell Death Dis. 2020;11(8):682.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4005_CR11","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/jcb.29433","volume":"121","author":"R Li","year":"2020","unstructured":"Li R, Weng L, Liu B, Zhu L, Zhang X, Tian G, et al. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K\/AKT\/mTOR-glycolysis signaling axis. J Cell Biochem. 2020;121(2):1986\u201397.","journal-title":"J Cell Biochem"},{"key":"4005_CR12","unstructured":"Li LY, Nie ZY, Zhang XY, Luo JM, Yang L, Wang Q et al. [The effect of si-PKM2 on proliferation and apoptosis of acute leukemic cells and its molecular Mechanism]. Zhongguo Shi Yan Xue ye Xue Za Zhi. 2021;29(5):1394\u2013402."},{"issue":"8","key":"4005_CR13","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt pathway and glucose metabolism: A dangerous liaison in cancer. Int J Biol Sci. 2024;20(8):3113.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4005_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43556-024-00229-4","volume":"5","author":"Y Hu","year":"2024","unstructured":"Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q. Tumor energy metabolism: implications for therapeutic targets. Mol Biomed. 2024;5(1):63.","journal-title":"Mol Biomed"},{"issue":"1","key":"4005_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1139\/bcb-2021-0305","volume":"100","author":"H-y Tang","year":"2022","unstructured":"Tang H-y, Guo J-q, Sang B-t, Cheng J-n. Wu X-m. PDGFR\u03b2 modulates aerobic Glycolysis in osteosarcoma HOS cells via the PI3K\/AKT\/mTOR\/c-Myc pathway. Biochem Cell Biol. 2022;100(1):75\u201384.","journal-title":"Biochem Cell Biol"},{"issue":"1","key":"4005_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1186\/s12885-024-12976-2","volume":"24","author":"L Gao","year":"2024","unstructured":"Gao L, Zhang R, Zhang W, Lan Y, Li X, Cai Q, et al. Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas. BMC Cancer. 2024;24(1):1252.","journal-title":"BMC Cancer"},{"issue":"6","key":"4005_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/WCO.0000000000001002","volume":"34","author":"T Graillon","year":"2021","unstructured":"Graillon T, Tabouret E, Chinot O. Chemotherapy and targeted therapies for meningiomas: what is the evidence? Curr Opin Neurol. 2021;34(6):857\u201367.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"4005_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41935-023-00382-x","volume":"14","author":"MA Mesrati","year":"2024","unstructured":"Mesrati MA, Brahim O, Boussaid M, Soiniya R, Mahjoub Y, Abdeljelil NB, et al. Intracranial meningioma: an unusual silent killer\u2014about two cases report and a literature review. Egypt J Forensic Sci. 2024;14(1):8.","journal-title":"Egypt J Forensic Sci"},{"issue":"19","key":"4005_CR19","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.3390\/ijms221910222","volume":"22","author":"JA Pawloski","year":"2021","unstructured":"Pawloski JA, Fadel HA, Huang Y-W, Lee IY. Genomic biomarkers of meningioma: a focused review. Int J Mol Sci. 2021;22(19):10222.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4005_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/neuros\/nyaa355","volume":"88","author":"WC Chen","year":"2021","unstructured":"Chen WC, Vasudevan HN, Choudhury A, Pekmezci M, Lucas C-HG, Phillips J, et al. A prognostic gene-expression signature and risk score for meningioma recurrence after resection. Neurosurgery. 2021;88(1):202\u201310.","journal-title":"Neurosurgery"},{"issue":"2","key":"4005_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tranon.2019.10.019","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Liu Y, Zhang J, Yu D, Li A, Song H, et al. Autocrine BMP4 signaling enhances tumor aggressiveness via promoting wnt\/\u03b2-catenin signaling in IDH1-mutant gliomas. Translational Oncol. 2020;13(2):125\u201334.","journal-title":"Translational Oncol"},{"issue":"10","key":"4005_CR22","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/biomedicines9101328","volume":"9","author":"C Noronha","year":"2021","unstructured":"Noronha C, Ribeiro AS, Taipa R, Castro DS, Reis J, Faria C, et al. Cadherin expression and EMT: A focus on gliomas. Biomedicines. 2021;9(10):1328.","journal-title":"Biomedicines"},{"issue":"5","key":"4005_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/biology12050729","volume":"12","author":"L Manfreda","year":"2023","unstructured":"Manfreda L, Rampazzo E, Persano L. Wnt signaling in brain tumors: A challenging therapeutic target. Biology. 2023;12(5):729.","journal-title":"Biology"},{"issue":"6","key":"4005_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s12282-022-01393-7","volume":"29","author":"M Haji Ghaffari","year":"2022","unstructured":"Haji Ghaffari M, Simonian M, Salimi A, Mirzadegan E, Sadeghi N, Nejadmoghaddam MR, et al. A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer. Breast Cancer (Tokyo Japan). 2022;29(6):1121\u201332.","journal-title":"Breast Cancer (Tokyo Japan)"},{"key":"4005_CR25","doi-asserted-by":"crossref","unstructured":"Deng T, Hou Y, Lin G, Feng C, Liu K, Chen W et al. A novel fibromodulin antagonist peptide RP4 exerts antitumor effects on colorectal cancer. Pharmaceutics. 2023;15(3).","DOI":"10.3390\/pharmaceutics15030944"},{"issue":"1","key":"4005_CR26","first-page":"8326591","volume":"2022","author":"X-H Fu","year":"2022","unstructured":"Fu X-H, Li J-P, Li X-Y, Tan Y, Zhao M, Zhang S-F, et al. M2-macrophage\u2010derived exosomes promote meningioma progression through TGF\u2010\u03b2 signaling pathway. J Immunol Res. 2022;2022(1):8326591.","journal-title":"J Immunol Res"},{"key":"4005_CR27","doi-asserted-by":"crossref","unstructured":"Zhou C, Sun J, Wu L, Liu C, Cheng Q, Xie S et al. LTBP2 down-regulated FGF2 to repress vascular smooth muscle cell proliferation and vascular remodeling in a rat model of intracranial aneurysm. Neurosci Lett. 2024:137988.","DOI":"10.1016\/j.neulet.2024.137988"},{"issue":"17","key":"4005_CR28","doi-asserted-by":"publisher","first-page":"e29207","DOI":"10.1097\/MD.0000000000029207","volume":"101","author":"J Zhao","year":"2022","unstructured":"Zhao J, Liu X, Cong K, Chang J, Shan H, Zheng Y. The prognostic significance of LTBP2 for malignant tumors: evidence based on 11 observational studies. Medicine. 2022;101(17):e29207.","journal-title":"Medicine"},{"issue":"3","key":"4005_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11500","volume":"24","author":"X Zhang","year":"2022","unstructured":"Zhang X, Tian C, Cheng J, Mao W, Li M, Chen M. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K\/AKT signaling pathway. Experimental Therapeutic Med. 2022;24(3):1\u201316.","journal-title":"Experimental Therapeutic Med"},{"key":"4005_CR30","doi-asserted-by":"publisher","first-page":"156535","DOI":"10.1016\/j.cyto.2024.156535","volume":"176","author":"S Singh","year":"2024","unstructured":"Singh S, Lathoria K, Umdor SB, Singh J, Suri V, Sen E. A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma. Cytokine. 2024;176:156535.","journal-title":"Cytokine"},{"key":"4005_CR31","doi-asserted-by":"publisher","first-page":"117257","DOI":"10.1016\/j.biopha.2024.117257","volume":"178","author":"Q Tang","year":"2024","unstructured":"Tang Q, Wu S, Zhao B, Li Z, Zhou Q, Yu Y, et al. Reprogramming of glucose metabolism: the hallmark of malignant transformation and target for advanced diagnostics and treatments. Biomed Pharmacother. 2024;178:117257.","journal-title":"Biomed Pharmacother"},{"key":"4005_CR32","doi-asserted-by":"crossref","unstructured":"Kooshan Z, C\u00e1rdenas-Piedra L, Clements J, Batra J, Glycolysis. The sweet appetite of the tumour microenvironment. Cancer Lett. 2024:217156.","DOI":"10.1016\/j.canlet.2024.217156"},{"key":"4005_CR33","doi-asserted-by":"crossref","unstructured":"Yadav D, Yadav A, Bhattacharya S, Dagar A, Kumar V, Rani R, editors. GLUT and HK: two primary and essential key players in Tumor glycolysis. Seminars in Cancer Biology; 2024: Elsevier.","DOI":"10.1016\/j.semcancer.2024.03.001"},{"key":"4005_CR34","doi-asserted-by":"crossref","unstructured":"Cheng H, Hua L, Tang H, Bao Z, Xu X, Zhu H et al. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44\/c-MYC\/LDHA axis. J Mol Cell Biol. 2024;15(10).","DOI":"10.1093\/jmcb\/mjad057"},{"issue":"1","key":"4005_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12967-023-04703-5","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Cheng Z, Cui Y, Xu S, Luan Q, Jing S, et al. PTPRH promotes the progression of non-small cell lung cancer via Glycolysis mediated by the PI3K\/AKT\/mTOR signaling pathway. J Translational Med. 2023;21(1):819.","journal-title":"J Translational Med"},{"issue":"6","key":"4005_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","volume":"100","author":"X Hu","year":"2020","unstructured":"Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, et al. PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic Glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020;100(6):801\u201311.","journal-title":"Lab Invest"},{"key":"4005_CR37","doi-asserted-by":"crossref","unstructured":"Yu L, Wei J, Liu P, editors. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Seminars in cancer biology. Elsevier; 2022.","DOI":"10.1016\/j.semcancer.2021.06.019"},{"issue":"1","key":"4005_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12032-022-01883-w","volume":"40","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li C, Zhu R, Jiapaer Z. ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway. Med Oncol. 2022;40(1):21.","journal-title":"Med Oncol"},{"issue":"4","key":"4005_CR39","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/ijms23041978","volume":"23","author":"B Pinker","year":"2022","unstructured":"Pinker B, Barciszewska A-M. mTOR signaling and potential therapeutic targeting in meningioma. Int J Mol Sci. 2022;23(4):1978.","journal-title":"Int J Mol Sci"},{"key":"4005_CR40","doi-asserted-by":"crossref","unstructured":"Pinker B, Barciszewska AM. mTOR signaling and potential therapeutic targeting in meningioma. Int J Mol Sci. 2022;23(4).","DOI":"10.3390\/ijms23041978"},{"issue":"3","key":"4005_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","volume":"26","author":"T Graillon","year":"2020","unstructured":"Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyri\u00e8re H, et al. Everolimus and octreotide for patients with recurrent meningioma: results from the phase II CEVOREM trial. Clin Cancer Research: Official J Am Association Cancer Res. 2020;26(3):552\u20137.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"4005_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10863-021-09924-1","volume":"53","author":"K Zhou","year":"2021","unstructured":"Zhou K, Lin J, Dai M, He Y, Xu J, Lin Q. KIFC1 promotes aerobic Glycolysis in endometrial cancer cells by regulating the c-myc pathway. J Bioenerg Biomembr. 2021;53:703\u201313.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"4005_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1568009620666201016121005","volume":"21","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam ER, Hashemi F, Daneshi S, et al. C-Myc signaling pathway in treatment and prevention of brain tumors. Curr Cancer Drug Targets. 2021;21(1):2\u201320.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"4005_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","volume":"23","author":"M Ala","year":"2022","unstructured":"Ala M. Target c-Myc to treat pancreatic cancer. Cancer Biol Ther. 2022;23(1):34\u201350.","journal-title":"Cancer Biol Ther"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04005-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:13:49Z","timestamp":1767050029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04005-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4005"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04005-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2299"}}